Murine CD8+ regulatory T lymphocytes: The new era

Human Immunology

Volumn 69, Issue 11, 2008, Pages 708-714

  Pomié, Céline ^a,b   Ménager Marcq, Ingrid ^a,b   van Meerwijk, Joost P M ^a,b,c  

^a INSERM   (France)

^b UNIVERSITÉ DE TOULOUSE   (France)

^c INSTITUT UNIVERSITAIRE DE FRANCE   (France)

Author keywords

CD8; Colitis; Immune regulation; Mouse; Rat

Indexed keywords

CD11 ANTIGEN; CD28 ANTIGEN; CD45RA ANTIGEN; CD8ALPHA ANTIGEN; INTERLEUKIN 2 RECEPTOR BETA; T LYMPHOCYTE RECEPTOR ALPHA CHAIN; T LYMPHOCYTE RECEPTOR BETA CHAIN; TRANSCRIPTION FACTOR FOXP3;

ARTICLE; AUTOIMMUNITY; CD25+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL ACTIVITY; EFFECTOR CELL; GRAFT REJECTION; GRAFT VERSUS HOST REACTION; HOMEOSTASIS; IMMUNE RESPONSE; IMMUNOLOGICAL TOLERANCE; IMMUNOPATHOLOGY; IMMUNOREGULATION; IN VITRO STUDY; IN VIVO STUDY; LYMPHOCYTE FUNCTION; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; T LYMPHOCYTE SUBPOPULATION;

ANIMALS; AUTOIMMUNITY; CD8-POSITIVE T-LYMPHOCYTES; IMMUNE TOLERANCE; INTESTINES; MICE; T-LYMPHOCYTE SUBSETS; T-LYMPHOCYTES, REGULATORY;

EID: 57149124653     PISSN: 01988859     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.humimm.2008.08.288     Document Type: Article

References (88)

1. Gershon R.K., and Kondo K. Cell interactions in the induction of tolerance: The role of thymic lymphocytes. Immunol 18 (1970) 723-737
2. Gershon R.K., and Kondo K. Infectious immunological tolerance. Immunology 21 (1971) 903-914
3. McCullagh P.J. The transfer of immunological competence to rats tolerant of sheep erythrocytes with lymphocytes from normal rats. Aust J Exp Biol Med Sci 48 (1970) 351-367
4. Steinmetz M., Minard K., Horvath S., McNicholas J., Srelinger J., Wake C., et al. A molecular map of the immune response region from the major histocompatibility complex of the mouse. Nature 300 (1982) 35-42
5. Kronenberg M., Steinmetz M., Kobori J., Kraig E., Kapp J.A., Pierce C.W., et al. RNA transcripts for I-J polypeptides are apparently not encoded between the I-A and I-E subregions of the murine major histocompatibility complex. Proc Natl Acad Sci USA 80 (1983) 5704-5708
6. Basten A., and Fazekas de St Groth B. Special regulatory T-cell review: T-cell dependent suppression revisited. Immunology 123 (2008) 33-39
7. Germain R.N. Special regulatory T-cell review: A rose by any other name: From suppressor T cells to Tregs, approbation to unbridled enthusiasm. Immunology 123 (2008) 20-27
8. Kapp J.A. Special regulatory T-cell review: Suppressors regulated but unsuppressed. Immunology 123 (2008) 28-32
9. Waldmann H. Special regulatory T cell review: The suppression problem. Immunology 123 (2008) 11-12
10. Cantor H., Shen F.W., and Boyse E.A. Separation of helper T cells from suppressor T cells expressing different Ly components. II. Activation by antigen: After immunization, antigen-specific suppressor and helper activities are mediated by distinct T-cell subclasses. J Exp Med 143 (1976) 1391-40
11. Jandinski J., Cantor H., Tadakuma T., Peavy D.L., and Pierce C.W. Separation of helper T cells from suppressor T cells expressing different Ly components. I. Polyclonal activation: suppressor and helper activities are inherent properties of distinct T-cell subclasses. J Exp Med 143 (1976) 1382-1390
12. van Meerwijk J.P.M., Marguerat S., Lees R.K., Germain R.N., Fowlkes B.J., and MacDonald H.R. Quantitative impact of thymic clonal deletion on the T cell repertoire. J Exp Med 185 (1997) 377-383
13. Hogquist K.A., Baldwin T.A., and Jameson S.C. Central tolerance: Learning self-control in the thymus. Nat Rev Immunol 5 (2005) 772-782
14. Bouneaud C., Kourilsky P., and Bousso P. Impact of negative selection on the T cell repertoire reactive to a self-peptide: A large fraction of T cell clones escapes clonal deletion. Immunity 13 (2000) 829-840
15. Stockinger B. T lymphocyte tolerance: From thymic deletion to peripheral control mechanisms. Adv Immunol 71 (1999) 229-265
16. Shevach E.M., DiPaolo R.A., Andersson J., Zhao D.M., Stephens G.L., and Thornton A.M. The lifestyle of naturally occurring CD4+ CD25+ Foxp3+ regulatory T cells. Immunol Rev 212 (2006) 60-73
17. Sakaguchi S., Ono M., Setoguchi R., Yagi H., Hori S., Fehervari Z., et al. Foxp3+ CD25+ CD4+ natural regulatory T cells in dominant self-tolerance and autoimmune disease. Immunol Rev 212 (2006) 8-27
18. Tang Q., and Bluestone J.A. The Foxp3+ regulatory T cell: A jack of all trades, master of regulation. Nat Immunol 9 (2008) 239-244
19. Floess S., Freyer J., Siewert C., Baron U., Olek S., Polansky J., et al. Epigenetic control of the Foxp3 locus in regulatory T cells. PLoS Biol 5 (2007) e38
20. Bienvenu B., Martin B., Auffray C., Cordier C., Becourt C., and Lucas B. Peripheral CD8+CD25+ T lymphocytes from MHC class II-deficient mice exhibit regulatory activity. J Immunol 175 (2005) 246-253
21. von Boehmer H. Mechanisms of suppression by suppressor T cells. Nat Immunol 6 (2005) 338-344
22. Cosmi L., Liotta F., Lazzeri E., Francalanci M., Angeli R., Mazzinghi B., et al. Human CD8+CD25+ thymocytes share phenotypic and functional features with CD4+CD25+ regulatory thymocytes. Blood 102 (2003) 4107-4114
23. Sugita S., Ng T.F., Schwartzkopff J., and Streilein J.W. CTLA-4+CD8+ T cells that encounter B7-2+ iris pigment epithelial cells express their own B7-2 to achieve global suppression of T cell activation. J Immunol 172 (2004) 4184-4194
24. Sugita S., Ng T.F., Lucas P.J., Gress R.E., and Streilein J.W. B7+ iris pigment epithelium induce CD8+ T regulatory cells; both suppress CTLA-4+ T cells. J Immunol 176 (2006) 118-127
25. Sugita S., Futagami Y., Horie S., and Mochizuki M. Transforming growth factor beta-producing Foxp3(+)CD8(+)CD25(+) T cells induced by iris pigment epithelial cells display regulatory phenotype and acquire regulatory functions. Exp Eye Res 85 (2007) 626-636
26. Sugita S., and Streilein J.W. Iris pigment epithelium expressing CD86 (B7-2) directly suppresses T cell activation in vitro via binding to cytotoxic T lymphocyte-associated antigen 4. J Exp Med 198 (2003) 161-171
27. Kapp J.A., Honjo K., Kapp L.M., Xu X., Cozier A., and Bucy R.P. TCR transgenic CD8+ T cells activated in the presence of TGFbeta express FoxP3 and mediate linked suppression of primary immune responses and cardiac allograft rejection. Int Immunol 18 (2006) 1549-1562
28. Chen W., Jin W., Hardegen N., Lei K.-j., Li L., Marinos N., et al. Conversion of peripheral CD4+CD25- naive T cells to CD4+CD25+ regulatory T cells by TGF-{beta} induction of transcription factor Foxp3. J Exp Med 198 (2003) 1875-1886
29. Benson M.J., Pino-Lagos K., Rosemblatt M., and Noelle R.J. All-trans retinoic acid mediates enhanced T reg cell growth differentiation, and gut homing in the face of high levels of co-stimulation. J Exp Med 204 (2007) 1765-1774
30. Joffre O., Santolaria T., Calise D., Al Saati T., Hudrisier D., Romagnoli P., et al. Prevention of acute and chronic allograft rejection with CD4+CD25+Foxp3+ regulatory T lymphocytes. Nat Med 14 (2008) 88-92
31. Liu J., Liu Z., Witkowski P., Vlad G., Manavalan J.S., Scotto L., et al. Rat CD8+ FOXP3+ T suppressor cells mediate tolerance to allogeneic heart transplants, inducing PIR-B in APC and rendering the graft invulnerable to rejection. Transpl Immunol 13 (2004) 239-247
32. Chang C.C., Ciubotariu R., Manavalan J.S., Yuan J., Colovai A.I., Piazza F., et al. Tolerization of dendritic cells by T(S) cells: The crucial role of inhibitory receptors ILT3 and ILT4. Nat Immunol 3 (2002) 237-243
33. Nakamura A., Kobayashi E., and Takai T. Exacerbated graft-versus-host disease in Pirb-/- mice. Nat Immunol 5 (2004) 623-629
34. Stein-Streilein J., and Streilein J.W. Anterior chamber associated immune deviation (ACAID): Regulation, biological relevance, and implications for therapy. Int Rev Immunol 21 (2002) 123-152
35. Streilein J.W., and Niederkorn J.Y. Characterization of the suppressor cell(s) responsible for anterior chamber-associated immune deviation (ACAID) induced in BALB/c mice by P815 cells. J Immunol 134 (1985) 1381-1387
36. Cone R.E., Li X., Sharafieh R., O'Rourke J., and Vella A.T. The suppression of delayed-type hypersensitivity by CD8+ regulatory T cells requires interferon-gamma. Immunology 120 (2007) 112-119
37. Sonoda K.H., Exley M., Snapper S., Balk S.P., and Stein-Streilein J. CD1-reactive natural killer T cells are required for development of systemic tolerance through an immune-privileged site. J Exp Med 190 (1999) 1215-1226
38. Nakamura T., Sonoda K.H., Faunce D.E., Gumperz J., Yamamura T., Miyake S., et al. CD4+ NKT cells, but not conventional CD4+ T cells, are required to generate efferent CD8+ T regulatory cells following antigen inoculation in an immune-privileged site. J Immunol 171 (2003) 1266-1271
39. Jiang L., Yang P., He H., Li B., Lin X., Hou S., et al. Increased expression of Foxp3 in splenic CD8+ T cells from mice with anterior chamber-associated immune deviation. Mol Vis 13 (2007) 968-974
40. D'Orazio T.J., Mayhew E., and Niederkorn J.Y. Ocular immune privilege promoted by the presentation of peptide on tolerogenic B cells in the spleen. II. Evidence for presentation by Qa-1. J Immunol 166 (2001) 26-32
41. Chattopadhyay S., O'Rourke J., and Cone R.E. Implication for the CD94/NKG2A-Qa-1 system in the generation and function of ocular-induced splenic CD8+ regulatory T cells. Int Immunol 20 (2008) 509-516
42. Hahn B.H., Singh R.R., Wong W.K., Tsao B.P., Bulpitt K., and Ebling F.M. Treatment with a consensus peptide based on amino acid sequences in autoantibodies prevents T cell activation by autoantigens and delays disease onset in murine lupus. Arthritis Rheum 44 (2001) 432-441
43. Hahn B.H., Singh R.P., La Cava A., and Ebling F.M. Tolerogenic treatment of lupus mice with consensus peptide induces Foxp3-expressing, apoptosis-resistant, TGF-beta secreting CD8+ T cell suppressors. J Immunol 175 (2005) 7728-7737
44. Singh R.P., La Cava A., Wong M., Ebling F., and Hahn B.H. CD8+ T cell-mediated suppression of autoimmunity in a murine lupus model of peptide-induced immune tolerance depends on Foxp3 expression. J Immunol 178 (2007) 7649-7657
45. Singh R.P., La Cava A., and Hahn B.H. pConsensus peptide induces tolerogenic CD8+ T cells in lupus-prone (NZB × NZW)F1 mice by differentially regulating Foxp3 and PD1 molecules. J Immunol 180 (2008) 2069-2080
46. Ito T., Hanabuchi S., Wang Y.H., Park W.R., Arima K., Bover L., et al. Two functional subsets of FOXP3+ regulatory T cells in human thymus and periphery. Immunity 28 (2008) 870-880
47. Faria A.M., and Weiner H.L. Oral tolerance. Immunol Rev 206 (2005) 232-259
48. Higgins P.J., and Weiner H.L. Suppression of experimental autoimmune encephalomyelitis by oral administration of myelin basic protein and its fragments. J Immunol 140 (1988) 440-445
49. Lider O., Santos L.M., Lee C.S., Higgins P.J., and Weiner H.L. Suppression of experimental autoimmune encephalomyelitis by oral administration of myelin basic protein. II. Suppression of disease and in vitro immune responses is mediated by antigen-specific CD8+ T lymphocytes. J Immunol 142 (1989) 748-752
50. Miller A., Lider O., and Weiner H.L. Antigen-driven bystander suppression after oral administration of antigens. J Exp Med 174 (1991) 791-798
51. Miller A., Lider O., Roberts A.B., Sporn M.B., and Weiner H.L. Suppressor T cells generated by oral tolerization to myelin basic protein suppress both in vitro and in vivo immune responses by the release of transforming growth factor beta after antigen-specific triggering. Proc Natl Acad Sci USA 89 (1992) 421-425
52. Ke Y., and Kapp J.A. Oral antigen inhibits priming of CD8+ CTL, CD4+ T cells, and antibody responses while activating CD8+ suppressor T cells. J Immunol 156 (1996) 916-921
53. Kapp J.A., Pierce C.W., Webb D.R., Devens B., Godfrey W., Fukuse S., et al. Characterization of the epitope recognized by a mAb that reacts differentially with murine suppressor T cells. Int Immunol 7 (1995) 1319-1330
54. Zimring J.C., Levery S.B., Kniep B., Kapp L.M., Fuller M., and Kapp J.A. CD75s is a marker of murine CD8(+) suppressor T cells. Int Immunol 15 (2003) 1389-1399
55. Zhou J., Carr R.I., Liwski R.S., Stadnyk A.W., and Lee T.D. Oral exposure to alloantigen generates intragraft CD8+ regulatory cells. J Immunol 167 (2001) 107-113
56. Donckier V., Wissing M., Bruyns C., Abramowicz D., Lybin M., Vanderhaeghen M.L., et al. Critical role of interleukin 4 in the induction of neonatal transplantation tolerance. Transplantation 59 (1995) 1571-1576
57. Laffont S., Coudert J.D., Garidou L., Delpy L., Wiedemann A., Demur C., et al. CD8+ T cell-mediated killing of donor dendritic cells prevents alloreactive T helper type-2 responses in vivo. Blood 108 (2006) 2257-2264
58. Field A.C., Caccavelli L., Bloch M.F., and Bellon B. Regulatory CD8+ T cells control neonatal tolerance to a Th2-mediated autoimmunity. J Immunol 170 (2003) 2508-2515
59. Xystrakis E., Dejean A.S., Bernard I., Druet P., Liblau R., Gonzalez-Dunia D., et al. Identification of a novel natural regulatory CD8 T-cell subset and analysis of its mechanism of regulation. Blood 104 (2004) 3294-3301
60. Guillonneau C., Hill M., Hubert F.X., Chiffoleau E., Herve C., Li X.L., et al. CD40Ig treatment results in allograft acceptance mediated by CD8CD45RC T cells, IFN-gamma, and indoleamine 2,3-dioxygenase. J Clin Invest 117 (2007) 1096-1106
61. Suzuki H., Kundig T.M., Furlonger C., Wakeham A., Timms E., Matsuyama T., et al. Deregulated T cell activation and autoimmunity in mice lacking interleukin-2 receptor beta. Science 268 (1995) 1472-1476
62. Rifa'i M., Kawamoto Y., Nakashima I., and Suzuki H. Essential roles of CD8+CD122+ regulatory T cells in the maintenance of T cell homeostasis. J Exp Med 200 (2004) 1123-1134
63. Ménager-Marcq I., Pomié P., Romagnoli P., and van Meerwijk J.P.M. CD8+CD28- regulatory T-lymphocytes prevent experimental inflammatory bowel disease in mice. Gastroenterology 131 (2006) 1775-1785
64. Endharti A.T., Rifa, Shi Z., Fukuoka Y., Nakahara Y., Kawamoto Y., et al. Cutting edge: CD8+CD122+ regulatory T cells produce IL-10 to suppress IFN-gamma production and proliferation of CD8+ T cells. IMs. J Immunol 175 (2005) 7093-7097
65. Lee Y.H., Ishida Y., Rifa'i M., Shi Z., Isobe K., and Suzuki H. Essential role of CD8+CD122+ regulatory T cells in the recovery from experimental autoimmune encephalomyelitis. J Immunol 180 (2008) 825-832
66. Yamagata T., Mathis D., and Benoist C. Self-reactivity in thymic double-positive cells commits cells to a CD8 alpha alpha lineage with characteristics of innate immune cells. Nat Immunol 5 (2004) 597-605
67. Rocha B. The extrathymic T-cell differentiation in the murine gut. Immunol Rev 215 (2007) 166-177
68. Izcue A., Coombes J.L., and Powrie F. Regulatory T cells suppress systemic and mucosal immune activation to control intestinal inflammation. Immunol Rev 212 (2006) 256-271
69. Poussier P., Ning T., Banerjee D., and Julius M. A unique subset of self-specific intraintestinal T cells maintains gut integrity. J Exp Med 195 (2002) 1491-1497
70. Hu D., Ikizawa K., Lu L., Sanchirico M.E., Shinohara M.L., and Cantor H. Analysis of regulatory CD8 T cells in Qa-1-deficient mice. Nat Immunol 5 (2004) 516-523
71. Li J., Goldstein I., Glickman-Nir E., Jiang H., and Chess L. Induction of TCR Vbeta-specific CD8+ CTLs by TCR Vbeta-derived peptides bound to HLA-E. J Immunol 167 (2001) 3800-3808
72. Ben-Nun A., Wekerle H., and Cohen I.R. Vaccination against autoimmune encephalomyelitis with T-lymphocyte line cells reactive against myelin basic protein. Nature 292 (1981) 60-61
73. Acha-Orbea H., Mitchell D.J., Timmermann L., Wraith D.C., Tausch G.S., Waldor M.K., et al. Limited heterogeneity of T cell receptors from lymphocytes mediating autoimmune encephalomyelitis allows specific immune intervention. Cell 54 (1988) 263-273
74. Urban J.L., Kumar V., Kono D.H., Gomez C., Horvath S.J., Clayton J., et al. Restricted use of T cell receptor V genes in murine autoimmune encephalomyelitis raises possibilities for antibody therapy. Cell 54 (1988) 577-592
75. Gaur A., Ruberti G., Haspel R., Mayer J.P., and Fathman C.G. Requirement for CD8+ cells in T cell receptor peptide-induced clonal unresponsiveness. Science 259 (1993) 91-94
76. Jiang H., Kashleva H., Xu L.X., Forman J., Flaherty L., Pernis B., et al. T cell vaccination induces T cell receptor Vbeta-specific Qa-1-restricted regulatory CD8(+) T cells. Proc Natl Acad Sci USA 95 (1998) 4533-4537
77. Tang X., Maricic I., Purohit N., Bakamjian B., Reed-Loisel L.M., Beeston T., et al. Regulation of immunity by a novel population of Qa-1-restricted CD8alphaalpha+TCRalphabeta+ T cells. J Immunol 177 (2006) 7645-7655
78. Soloski M.J., DeCloux A., Aldrich C.J., and Forman J. Structural and functional characteristics of the class IB molecule, Qa-1. Immunol Rev 147 (1995) 67-89
79. Lohse A.W., Mor F., Karin N., and Cohen I.R. Control of experimental autoimmune encephalomyelitis by T cells responding to activated T cells. Science 244 (1989) 820-822
80. Seo S.K., Choi J.H., Kim Y.H., Kang W.J., Park H.Y., Suh J.H., et al. 4-1BB-mediated immunotherapy of rheumatoid arthritis. Nat Med 10 (2004) 1088-1094
81. Myers L., Croft M., Kwon B.S., Mittler R.S., and Vella A.T. Peptide-specific CD8 T regulatory cells use IFN-gamma to elaborate TGF-beta based suppression. J Immunol 174 (2005) 7625-7632
82. Myers L., Takahashi C., Mittler R.S., Rossi R.J., and Vella A.T. Effector CD8 T cells possess suppressor function after 4-1BB and Toll-like receptor triggering. Proc Natl Acad Sci USA 100 (2003) 5348-5353
83. Najafian N., Chitnis T., Salama A.D., Zhu B., Benou C., Yuan X., et al. Regulatory functions of CD8+CD28- T cells in an autoimmune disease model. J Clin Invest 112 (2003) 1037-1048
84. Brimnes J., Allez M., Dotan I., Shao L., Nakazawa A., and Mayer L. Defects in CD8+ regulatory T cells in the lamina propria of patients with inflammatory bowel disease. J Immunol 174 (2005) 5814-5822
85. Allez M., Brimnes J., Dotan I., and Mayer L. Expansion of CD8+ T cells with regulatory function after interaction with intestinal epithelial cells. Gastroenterology 123 (2002) 1516-1526
86. Joffre O., Gorsse N., Romagnoli P., Hudrisier D., and van Meerwijk J.P.M. Induction of antigen-specific tolerance to bone marrow allografts with CD4+CD25+ T lymphocytes. Blood 103 (2004) 4216-4221
87. Joffre O., and van Meerwijk J.P.M. CD4+CD25+ regulatory T lymphocytes in bone marrow transplantation. Semin Immunol 18 (2006) 128-135
88. Xystrakis E., Cavailles P., Dejean A.S., Cautain B., Colacios C., Lagrange D., et al. Functional and genetic analysis of two CD8 T cell subsets defined by the level of CD45RC expression in the rat. J Immunol 173 (2004) 3140-3147